Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for glucagon- like peptide 2
Most Correlated Studies
- Hypothalamus of N171-82Q model of Huntington's disease euglycemic agent treated
- Left heart ventricles from mice treated with Liraglutide on on calorie-restriced diet
- Insulinoma INS-1 cells treated with Glucagon-like peptide 1 and its peptide mimetic BMS-21
- Pancreatic cell lines treated with chromatin-targeting small molecules
- Hippocampus tissue from mice treated with exendin-4 and subjected to traumatic brain injury
Most Relevant Literature
- Gaps in glucagon fills among commercially insured patients receiving a glucagon prescription.
- Brief overview: glucagon history and physiology.
- Designer GLP1 poly-agonist peptides in the management of diabesity.
- Corrination mitigates peptide aggregation as exemplified for Glucagon.
- The molecular pharmacology of glucagon agonists in diabetes and obesity.
Most Relevant Clinical Trials
- Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon Like Peptide 2
- Effect of Glucagon-like Peptide 2 on Gallbladder Motility After a Meal in Young, Healthy Male Subjec…
- Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal F…
- The Importance of Glucagon-Like Peptide-2 (GLP-2)in Mesenteric Bloodflow in Humans
- Effect of the Enteric Hormone Glucagon-Like Peptide (GLP-2) on the Intestinal Blood Flow in Patients…
